» Articles » PMID: 16904315

Towards a Pan-European Consensus on the Treatment of Patients with Colorectal Liver Metastases

Overview
Journal Eur J Cancer
Specialty Oncology
Date 2006 Aug 15
PMID 16904315
Citations 251
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC) caused nearly 204,000 deaths in Europe in 2004. Despite recent advances in the treatment of advanced disease, which include the incorporation of two new cytotoxic agents irinotecan and oxaliplatin into first-line regimens, the concept of planned sequential therapy involving three active agents during the course of a patient's treatment and the integrated use of targeted monoclonal antibodies, the 5-year survival rates for patients with advanced CRC remain unacceptably low. For patients with colorectal liver metastases, liver resection offers the only potential for cure. This review, based on the outcomes of a meeting of European experts (surgeons and medical oncologists), considers the current treatment strategies available to patients with CRC liver metastases, the criteria for the selection of those patients most likely to benefit and suggests where future progress may occur.

Citing Articles

Survival Outcomes with Regorafenib and/or Trifluridine/Tipiracil Sequencing to Rechallenge with Third-Line Regimens in Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Subgroup Comparison from the ReTrITA Study.

Signorelli C, Calegari M, Anghelone A, Passardi A, Frassineti G, Bittoni A Curr Oncol. 2024; 31(12):7793-7808.

PMID: 39727697 PMC: 11674570. DOI: 10.3390/curroncol31120574.


Comparative efficacy of microwave ablation and radiofrequency ablation for treating metastatic liver cancer: a systematic review and meta-analysis.

Li Z, Yan T, Cai X Front Oncol. 2024; 14:1473780.

PMID: 39540156 PMC: 11557459. DOI: 10.3389/fonc.2024.1473780.


Mesenchymal stem cell-derived exosomes carrying miR-486-5p inhibit glycolysis and cell stemness in colorectal cancer by targeting NEK2.

Cui F, Chen Y, Wu X, Zhao W BMC Cancer. 2024; 24(1):1356.

PMID: 39506654 PMC: 11539302. DOI: 10.1186/s12885-024-13086-9.


Editorial: Insights in PET and SPECT: 2023.

Petretta M, Nappi C, Cuocolo A Front Nucl Med. 2024; 3:1342672.

PMID: 39355025 PMC: 11440878. DOI: 10.3389/fnume.2023.1342672.


Histopathological Growth Patterns Determine the Outcomes of Colorectal Cancer Liver Metastasis Following Liver Resection.

Krzywon L, Lazaris A, Petrillo S, Zlotnik O, Gao Z, Metrakos P Cancers (Basel). 2024; 16(18).

PMID: 39335120 PMC: 11430747. DOI: 10.3390/cancers16183148.